5.Erdheim-Chester Disease Presenting as an Anterior Mediastinal Tumor without Skeletal Involvement.
Kanghoon LEE ; Hyeong Ryul KIM ; Jin ROH ; You Jung OK ; Bo Bae JEON ; Young Woong KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2018;51(3):223-226
Erdheim-Chester disease (ECD) is a form of non–Langerhans cell histiocytosis that most commonly involves the skeletal system. We report an unusual case of ECD presenting as an anterior mediastinal tumor without skeletal involvement. A 60-year-old man with no remarkable medical history was referred for evaluation of a mediastinal mass. The patient underwent surgical excision of the tumor via video-assisted thoracoscopic surgery. Histologic examination revealed marked proliferation of atypical histiocytes with sclerosis, and the results of immunohistochemical staining were suggestive of ECD.
Erdheim-Chester Disease*
;
Histiocytes
;
Histiocytosis
;
Humans
;
Mediastinum
;
Middle Aged
;
Sclerosis
;
Thoracic Surgery, Video-Assisted
6.Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report
Yeoun Eun SUNG ; Yoon Seo LEE ; Jieun LEE ; Kyo Young LEE
Journal of Pathology and Translational Medicine 2018;52(3):183-190
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis and multisystem disease. First described in 1930, there are no more than 750 cases reported. The etiology remains unknown, but a majority of cases of ECD and Langerhans cell histiocytosis were found to have clonal mutations involving genes of the mitogen-activated protein kinase pathway. We recently encountered a 53-year-old male patient with extensive ECD involving the systemic lymph nodes, pleura, liver, and long bones clinically mimicking malignant lymphoma. Biopsies were performed at multiple sites, including a pleural mass, an external iliac lymph node, bone marrow, and the liver. Based on histopathological and immunohistochemical findings of positivity for CD68 and negativity for CD1a and S-100, the patient was diagnosed with ECD. Interferon-α was administered as the first-line treatment, but the patient rapidly progressed to hepatic failure after 2 months of treatment. We report this rare case of ECD clinically mimicking malignant lymphoma and diagnosed by careful pathological review.
Biopsy
;
Bone Marrow
;
Erdheim-Chester Disease
;
Histiocytosis
;
Histiocytosis, Langerhans-Cell
;
Humans
;
Liver Failure
;
Liver
;
Lymph Nodes
;
Lymphoma
;
Male
;
Middle Aged
;
Pleura
;
Protein Kinases
;
Spine
7.A Case of Erdheim-Chester Disease Developed during Treatment of Leukemia in a Child.
Joon Pyo HONG ; Won Ki AHN ; Joo Yeon LIM ; Jo Eun JUNG ; Seung Min HAHN ; Jung Woo HAN ; Chuhl Joo LYU
Clinical Pediatric Hematology-Oncology 2018;25(1):66-70
Erdheim-Chester disease (ECD) is a rare non-Langerhan's cell histiocytosis disorder characterized by replacement of normal tissue by lipid-laden histiocytes affecting various organs. A few pediatric cases have been reported worldwide. Here we present a child with leukemia who was diagnosed as ECD. A 2-year and 11-month old boy diagnosed with high risk acute lymphoblastic leukemia (ALL) at the age of 17 months, received allogeneic hematopoietic stem cell transplantation (HSCT) at the age of 2 years old. Six months after the transplantation, the patient was admitted to the hospital with palpable left calf nodules. Bone marrow study suggested ECD without leukemia with complete chimerism status. Excisional biopsy of the left calf nodule showed ‘aggregation of non-Langerhan's cell type epitheloid histiocytes’; clinically suggestive of ECD. The patient was started on vinblastine and corticosteroid treatment.
Biopsy
;
Bone Marrow
;
Child*
;
Chimerism
;
Erdheim-Chester Disease*
;
Hematopoietic Stem Cell Transplantation
;
Histiocytes
;
Histiocytosis
;
Humans
;
Leukemia*
;
Male
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Vinblastine
8.Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart.
Pengcheng ZHU ; Naping LI ; Lu YU ; Mariajose Navia MIRANDA ; Guoping WANG ; Yaqi DUAN
Cancer Research and Treatment 2017;49(2):553-558
Histiocytosis is an uncommon disease characterized by excessive accumulation of histiocytes. Here, we report a rare case of non-Langerhans-cell histiocytosis in a 51-year-old woman who presented with severe symptoms of pericardial effusion. Radiologic investigation also detected multiple bone (lower limbs, vertebrae, ribs, and ilium) lesions. Resected pericardium showed abundant mono- or multi-nucleated non-foamy histiocytes (CD68⁺/CD163⁺/S-100⁺/CD1α⁻/langerin⁻) in a fibroinflammatory background. The histiocytes demonstrated emperipolesis of lymphocytes, a hallmark feature of Rosai-Dorfman disease (RDD). However, molecular analysis revealed a BRAF V600E mutation of the proliferating histiocytes, highlighting the neoplastic features frequently observed in another non-Langerhans-cell histiocytosis known as Erdheim-Chester Disease (ECD). We consider this case to be a unique presentation of ECD harboring some RDD-like cells with emperipolesis, but not a case of RDD with a BRAF mutation concerning its clinical manifestation (involvement of the heart and bones) and neoplastic features.
Emperipolesis*
;
Erdheim-Chester Disease*
;
Extremities
;
Female
;
Heart*
;
Histiocytes
;
Histiocytosis
;
Histiocytosis, Non-Langerhans-Cell
;
Histiocytosis, Sinus
;
Humans
;
Lymphocytes
;
Middle Aged
;
Pericardial Effusion
;
Pericardium
;
Ribs
;
Spine
9.Successful Treatment of Erdheim-Chester Disease with Multisystemic Involvement in a 4-year-old Child by Interferon-α and Corticosteroid
Jung Won HWANG ; Chang Hoon AN ; Min Kyung LEE ; Pyoung Han HWANG
Clinical Pediatric Hematology-Oncology 2017;24(1):69-74
Erdheim-Chester disease (ECD) is a rare form of proliferative non-Langerhans cell histiocytosis that involves multiple organs and is associated with a high mortality. The prognosis of ECD is variable, and it mainly depends on the involved anatomic sites. The treatment modalities have not been standardized, but interferon-α (IFN-α) has been reported to be effective in the management of ECD. ECD usually affects middle aged individuals with a slight male predominance but is extremely rare in children. We present an uncommon case of a 4-year-boy diagnosed with ECD who was treated with IFN-α and corticosteroid. He remained disease-free for 3 years after the completion of treatment.
Child
;
Child, Preschool
;
Erdheim-Chester Disease
;
Histiocytosis
;
Humans
;
Male
;
Middle Aged
;
Mortality
;
Prognosis
10.Neurological Involvement in Erdheim-Chester Disease.
Miriam ALVAREZ-ALVAREZ ; Ronald MACIAS-CASANOVA ; M Angeles FIDALGO-FERNANDEZ ; Jose Pablo MIRAMONTES GONZALEZ
Journal of Clinical Neurology 2016;12(1):115-116
No abstract available.
Erdheim-Chester Disease*

Result Analysis
Print
Save
E-mail